EMBO Molecular Medicine

SJR Rank #629H-index: 162SJR: 3.277Best quartile: Q1Open AccessAPC: US$7,990Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media Deutschland GmbH

Country

Germany

Type

journal

SJR by Edition

2022202501234

Subject Categories

  • Molecular MedicineQ1

Areas: Biochemistry, Genetics and Molecular Biology

Most published research topics

Mitochondrial Function and PathologyImmune Cell Function and InteractionCRISPR and Genetic EngineeringRNA modifications and cancerAlzheimer's disease research and treatmentsEpigenetics and DNA MethylationCancer Cells and MetastasisCAR-T cell therapy researchAutophagy in Disease and TherapyImmunotherapy and Immune Responses

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

2022202504590135180

Detailed Information

ISSN

1757-4676, 1757-4684

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

6.69

References per Document

65.24

Coverage

2009-2026

Scope

EMBO Molecular Medicine is the top open access journal in the field of experimental medicine dedicated to science at the interface between translational and clinical research and basic life sciences. We welcome original studies performed in cells and/or animals provided that they demonstrate evident human disease relevance. We encourage submissions of first-in-human studies and analyses of patient samples. EMBO Molecular Medicine publishes research papers as full-length Articles, short Reports and Resource articles. In addition, the journal publishes Editorials and Reviews in innovative formats that target a broad and non-specialized audience, as well as News & Views, Opinions and Commentaries.

Metrics from SCImago Journal Rank 2025. View on SCImago